‘The way they treat us is worse than the disease’: A qualitative study of the experiences of people with drug-resistant tuberculosis at healthcare facilities in Lagos, Nigeria

‘The way they treat us is worse than the disease’: A qualitative study of the experiences of people with drug-resistant tuberculosis at healthcare facilities in Lagos, Nigeria | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article ‘The way they treat us is worse than the disease’: A qualitative study of the experiences of people with drug-resistant tuberculosis at healthcare facilities in Lagos, Nigeria Olusola A. Adejumo, Firoza Haffejee, Olusoji Daniel, Champaklal Jinabhai This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-6397399/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background: This study explored the stigma experiences of people with drug-resistant tuberculosis at health facilities in Lagos, Nigeria. Methods: Focus group discussions were conducted with individuals receiving treatment for drug-resistant tuberculosis at five treatment centers in Lagos. Thematic analysis was conducted. Results: The participants complained about the poor attitudes of healthcare workers, which they described as rude, hostile, and demeaning. These poor attitudes led some participants to consider abandoning treatment, whereasothers wished that they knew where to lodge complaints against healthcare workers. The participantsfelt humiliated, and some described the feeling as worse than the disease symptoms. The counselling by healthcare workers about the use of separate cutlery and self-isolation at home evoked feelings of loneliness at home, which was disapproved of by many participants. Conclusion: Reducing healthcare-associated stigma will require training healthcare workers on how to engage with people living with tuberculosis and their families, as well as providingnecessary infrastructural support that will make healthcare workers feel safe working among people living with tuberculosis. There is a need for stigma reduction intervention research in Nigeria, as well as learning from other settings that have achieved relative success. Stigma healthcare workers drug-resistant tuberculosis Nigeria Introduction Tuberculosis (TB) is a stigmatised disease affecting mainly socially disadvantaged people, such as poor people, prisoners and refugees, and people living with HIV/AIDS [ 1 ]. In most high TB-burden societies, TB-related stigma is a major sociocultural factor affecting the disease experience of people living with TB (PLWTB) because it influences the attitudes and behaviors of the community towards them [ 2 ]. It is shaped by deep-rooted myths and customs, incorrect perceptions and belief systems, and the culture of healthcare institutions [ 3 – 5 ]. TB-related stigma can affect the health-seeking and healthcare-seeking behavior of symptomatic individuals. It hinders the disclosure of disease to family members and friends, encourages community spread, and undermines TB control efforts [ 6 ]. Because of the fear of contagion, many PLWTB are not treated well by family members, friends, neighbours, or healthcare workers (HCWs), which may lead to low self-esteem, feelings of shame and guilt, isolation, and psychological distress [ 6 ]. TB-related stigma is common among people with drug-resistant TB (PwDR-TB) because of the longer duration of treatment, the perceived severity of the disease, and the shame associated with poor treatment outcomes [ 7 ]. Stigma is a social construct comprising two significant components: identifying a differentiating trait or attribute and labelling or discrediting the individual due to that trait [ 8 ]. The attitudes of the community, especially HCWs, towards PLWTB may impact the timing, place, duration, and effectiveness of the care they receive [ 9 , 10 ]. HCWs occupy a position that can define a disease with negative attributes and influence the community's perception of it, consequently reinforcing the stigma attached to the disease by the community [ 11 ]. TB is still a disease of public health concern in Nigeria despite all TB control efforts. Nigeria is one of the 30 high-burden countries for TB, accounting for 87% of the global incidence of TB cases. Among the 408,500 people diagnosed with drug-resistant TB (DR-TB) in 2022 globally, 57% were not enrolled, and Nigeria is among the 10 countries that accounted for 70% of the gap in treatment initiation [ 12 ]. Studies from high-burden TB countries such as Nigeria, Ethiopia, and China have reported a high prevalence of TB-related stigma [ 13 – 15 ]. The poor treatment of PLWTB in healthcare settings has been documented. Reports from Ghana and India have shown that HCWs are unfriendly towards, shunned, shouted at, avoided, disrespected, and discriminated against PLWTB [ 2 , 16 ]. Another qualitative study from Ghana revealed that the isolation and precautionary practices and behaviours of HCWs towards PLWTB exposed them to stigmatisation in the community [ 11 ]. TB cannot be controlled without strategies in place to reduce stigma, and TB control in Nigeria is crucial to global control due to its high prevalence in the country. Based on the above narrative, TB patients' experiences in Nigeria's healthcare facilities require further exploration. Unfortunately, there is a dearth of such studies in Nigeria. This study examines the stigma experiences of PwDR-TB in healthcare facilities in Lagos, Nigeria. Methods This study was part of a larger study that assessed the moderating role of social support in the associations among experienced stigma, anxiety, depression and loneliness among PwDR-TB in Lagos, Nigeria [ 17 ]. The study was conducted in Lagos state, Nigeria, between September and December 2023. Lagos State is a commercial hub in Nigeria, with an estimated population of 21 million. The state is divided into 20 local government areas (LGAs) and 37 local council development areas (LCDAs). The participants were drawn from five DR-TB outpatient clinics in Lagos State. The study received ethical approval from the Institutional Research Ethics Committee of the Durban University of Technology, South Africa (IREC 066/230) and the Health Research and Ethics Committee of the Lagos State University Teaching Hospital (LREC/06/10/2179). The Lagos State Ministry of Health granted permission for the interviews with participants. The data were collected in five DR-TB treatment centers across Lagos State between February and April 2024. The five centers were purposively selected because of their geographical representation and diversity of patients, as well as their high volume of clinic attendance. Furthermore, patients reported unpleasant discriminatory experiences in some of these health facilities. Details about the study site selection were published previously [ 17 ]. Five focus group discussions (FGDs) were conducted, one at each of the selected health facilities, and 53 participants (27 males and 26 females) aged 18–53 years participated in the discussions. Discussions were held at the outpatient clinic. Participants who took part in the larger study were invited to participate in the FGDs. Eligible participants were people who commenced DR-TB treatment within three months of the interview or who had completed treatment and were not younger than 18 years [ 17 ]. Details of the focus group participants are shown in Table 1. The focus groups were held at the health facility after the outpatient clinic and were moderated by the first author. Three research assistants were trained to assist with data collection, including recording discussions on audio tapes, note-taking, and transcribing the audio tapes. Each interview consisted of 9–12 participants and lasted 60–75 minutes. Focus group sessions were conducted in English and pidgin English using a focus group guide developed for this study (See supplementary file 1). Two bilingual research assistants translated and transcribed the recorded audio tapes verbatim within 48 hours after the data collection activity. After this, the first author and another research assistant, who had not participated in the initial transcription, used the audio tapes and field notes to verify the transcriptions and ensure that the participants' words were accurately preserved and that correct transcriptions were produced. The whole team was involved in resolving conflicts in interpretation and achieving a consensus. All coauthors read the transcripts several times and scrutinised them. A codebook was developed, and the transcripts were tabulated into three themes to facilitate comparison by two coauthors. These themes encompass the attitudes of healthcare workers, the effects of these attitudes, and the isolation that results from the education of healthcare workers. The coders discussed the data to ensure consistency in the meaning of the codes and assure interrater reliability. Verbatim quotations were selected to represent repeated discussions and ideas. Results 1. Attitudes of health workers Many participants complained about the attitudes of the HCWs. They described their attitudes as demeaning because the HCWs were very rude, shouted at some, and made some uncomplimentary remarks about others. … on my first visit here, I felt like the whole world was against me; the nurse made me think I was different, that there was something wrong with me, and she did not want me to come close to her. I don’t want to come here if I can buy the medication elsewhere, I won’t come here… (female, participant, 38 years old, FGD 2) ….. when I arrived at the hospital, I gave the doctor the test results. Immediately, she saw what was there; she said, 'Madam, go outside.' She then went and put on two face masks. She asked anybody who sat beside me to move away from me. When more people arrived, she chased me away from the clinic and asked me to sit outside. I fell while trying to exit the clinic. The disgrace was too much (female participant, 43 years old, FGD 5) Some of the participants wanted to abandon treatment because of the way they were attended to. Some even wish to die because of the attitudes of HCWs. ……. We sat down to see the doctor. When the nurse collected our test results, she shouted, "Go and sit down first.” She shouted at us to stand up and chased us away like animals. As we tried to move out of the place quickly, my child hit his head on an iron. I was so embarrassed, I thought of abandoning the treatment and dying …. (female participant, 45 years old, FGD 4). Some participants wished that they could report the HCWs to a higher authority for their bad attitudes, but some could not take this step because they did not want people to know that they had DR-TB. … the moment the woman saw my result, her attitude towards me changed; she shouted and embarrassed me. People asked me what went wrong. If I had the power, I would have reported her because I was treated as if I had leprosy….(male participant, 43 years old, FGD 1) …I had to endure the way the health workers treated me; I felt terrible, but I kept it to myself. I am the sick one, and I don’t want anybody to know I have TB…. (male participant, 48 years old, FGD 3) 2. Effects of healthcare workers’ attitudes Some participants reported experiencing adverse effects due to the poor attitudes of healthcare workers. Some felt humiliated, and some described the experience as being worse than the symptoms and the side effects of the drugs. …..the way I am being treated matters more to me than the TB itself; my first experience at the health facility was terrible (female participant, 25 years old, FGD 3). ……… I told him it’s not about the free medication; it’s about the humiliation (female participant, 35 years old, FGD 2) Owing to the attitudes of HCWs, some participants reported that it took courage to visit healthcare facilities to receive treatment. They could have opted for other options if possible. …... It takes courage to come here; the way I am being treated could increase the problems I already have. If there were other options, I would not come here again… (male participant, 41 years old, FGD 5) All the participants agreed that discriminatory behaviours were worse at the health facility than in the community. They reported that because they do not usually disclose their sickness to neighbours and friends, they do not become stigmatised. When asked if there is any other place they are discriminated against more than the health facility, they all chorused, “nowhere is worse than the health facility.” …Nowhere was I treated poorly except at the health facility. In the neighbourhood, nobody can know you have the disease… (male participant, 43 years old, FGD 2) … this (referring to the hospital) is where we wear a face mask; at home, we are just like any other person; no one knows what’s wrong with us. (male participant, 25 years old, FGD 1) 3. Healthcare workers were responsible for isolation practices at home. Many participants recounted the health education provided by HCWs. This includes unfounded practices, which involve using separate cutlery, sleeping in separate rooms, and avoiding the items used by PLWTB. This advice caused severe emotional trauma to the PLWTB. ….. they (the healthcare workers) usually ask me if I am using my medications and who I live with. They advised that I should not share utensils with anyone, use my face mask properly, and they told me to ensure that I don’t miss my drugs and always come for check-ups. (male participant, 20 years old, FGD 3). …I became lonely. Even my wife now stays away from me. We were sleeping in the same room, but now she is far from me. They advised us not to share anything (male participant, 45 years old, FGD 1) However, some family members showed a greater understanding of their loved ones. They were cognizant of the psychological effects of not sharing items within the household. …at the hospital, they told us that my husband should not share my spoon or share a cup or anything with me. However, my husband refused; he said he did not want what they said would affect me (female participant, 42 years old, FGD 2). Discussion This study provides insight into the experiences of PwDR-TB at healthcare facilities. Health professionals hold a privileged position to shape society’s perspective on any disease, owing to their specialised knowledge and social authority. Therefore, any human differences labelled by health professionals are accepted by society [ 18 ]. In some African countries, the practices and attitudes of HCWs are associated with stigmatisation. HCWs blame and impose restrictive practices that promote stigma. For example, in Ghana, HCWs impose that relatives are not allowed to see the PLWTB, shout at patients, run away when patients approach them and prohibit burial rites for people who die of TB [ 2 , 11 ]. In South Africa, poor attitudes toward providing grants, information, or treatment for TB have contributed to stigmatisation [ 18 ]. In Ethiopia, private providers are preferred over public TB healthcare providers because of the associated stigma [ 19 ]. This study highlights the struggles and challenges faced by PwDR-TB at healthcare facilities in Lagos, Nigeria. They were exposed to a system that labelled them as different and dangerous. They had to cope with the demeaning attitudes and behaviours of HCWs. These experiences were previously documented [ 20 , 21 ]. All the participants echoed that their greatest stigma challenge was at the healthcare facility. Many of the participants lamented the treatment they received from some HCWs. One participant described the treatment at the healthcare facility as worse than the symptoms of DR-TB. They craved acceptance, understanding, and empathy from the HCWs. We previously reported that social support reduced the effects of stigma on anxiety, loneliness, and depression among PwDR-TB in Lagos [ 17 ]. Getting the needed support from HCWs will significantly reduce the burden of DR-TB treatment. Studies have shown that HCWs working in DR-TB wards are hostile to patients because of the fear of infection [ 22 – 24 ], poor workplace infection prevention and control practices [ 24 , 25 ], lack of knowledge of infection control (IC) guidelines [ 22 , 25 ] and lack confidence in the facility’s ability to provide DR-TB care [ 22 ]. There is a paucity of TB stigma reduction intervention programs. A study indicated that training HCWs in IC and enhancing administrative and operational IC standards could help reduce barriers to implementing IC but not the fear of infection [ 26 ]. The provision of infrastructure for sustainability must support the training of HCWs. This will reduce the stigma faced by HCWs working with PLWTB experience from colleagues not working with PLWTB. There is a need for continual mentoring and supportive supervision. This is essential to HCWs’ confidence in providing DR-TB care [ 22 ]. Faith-based interventions that have improved the quality of life among people living with HIV/AIDS and financial aid could strengthen PwDR-TB resilience to stigma [ 27 ]. In conclusion, this study helps elucidate the stigma experienced by PwDR-TB in healthcare facilities. This study also shows that TB-related stigma could be significantly reduced if healthcare-associated stigma is minimised. To address stigma, there is a need for patient education and a support structure to build resilience and empower patients as they navigate the disease. Nigeria can learn from Ethiopia and Nicaragua, where small groups of patients often meet to support one another throughout the treatment period [ 28 ]. This will help reduce the social isolation that patients typically experience. There is a need for community engagement, which provides an enabling environment for PLWTB to share their experiences and advocate for changes in social norms that reinforce stigma. Additionally, there is a need to train HCWs to engage PLWTB and their families, provide the necessary infrastructure to optimise IC in healthcare facilities and offer supportive supervision and mentoring to HCWs. There is a need for stigma reduction intervention research in Nigeria and learning from other settings that have achieved relative success. Abbreviations DR-TB Drug-resistant tuberculosis FGDs Focus Group Discussions HCWs Healthcare workers HIV/AIDS Human immune deficiency syndrome/ Acquired Immune deficiency syndrome IC Infection control LCDAs Local Council Development Areas LGAs Local Government Areas PLWTB People living with tuberculosis TB Tuberculosis PwDR-TB People with drug-resistant tuberculosis Statements and declarations Ethical approval: This study was performed in accordance with the principles of the Declaration of Helsinki. Approval was granted by the Health Research and Ethics Committee of the Lagos State University Teaching Hospital (LREC/06/10/2179) and the Institutional Research Ethics Committee of Durban University of Technology, South Africa (IREC 066/230). Gatekeepers’ permission to interview participants was obtained from the Lagos State Ministry of Health and the medical directors of the DR-TB treatment centres where participants were recruited. Informed consent: Written informed consent was obtained from all participants included in the study. The study's objectives were explained to the participants. They were also informed that participation or nonparticipation in the study would not affect the provision of healthcare services. In addition, they were told that they were free to withdraw their consent at any time during the study. The data were anonymised, and personal identifiers were not obtained. Consent for publication: Not applicable. Availability of data and materials: T he datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Competing interest: The authors have no relevant financial or nonfinancial interests to disclose. Funding: The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. Authors' contributions: OAA conceived the study, analysed the data, and prepared the manuscript. OAA and FH were involved in the study design, literature search and coding of the transcripts. CJ, OD and FH were involved in interpreting the data and coding. FH, CJ and OD critically revised the manuscript for intellectual content. All the authors read and approved the final manuscript. OAA, FH and OD are guarantors of the manuscript. Acknowledgements: The authors wish to acknowledge the Lagos State Ministry of Health and the Lagos State TB and Leprosy Control Programme for granting permission to conduct this study. We also acknowledge the assistance and support of the management of the DR-TB treatment centres where the study was conducted. Special thanks to Nnenna Karen Ihezie for working tirelessly during the coding of the transcripts. References Ashaba, C., Musoke, D., Wafula, S. T. and Konde-Lule J. 2021 Stigma among tuberculosis patients and associated factors in urban slum populations in Uganda. Afri Health Sci, 21(4),1640-1650. Dodor, E. A. and Kelly, S. J. 2010. Manifestations of tuberculosis stigma within the healthcare system: the case of Sekondi-Takoradi Metropolitan district in Ghana. Health Policy, 98,195-202. Courtwright, A. and Turner, A. N. 2010. Tuberculosis and stigmatization: pathways and interventions. Public Health Rep , 125, 34-42. Nuttall, C., Fuady, A., Nuttall, H., Dixit, K., Mansyur, M. and Wingfield, T. 2022. Interventions pathways to reduce tuberculosis-related stigma: a literature review and conceptual framework. Infect Dis Poverty, 11(101). https://doi.org/10.1186/s40249-022-01021-8 Chen, X., Du, L., Wu, R., Xu, J., Ji, H., Zhang, Y., Zhu, X. and Zhou, L. 2021. Tuberculosis-related stigma and its determinants in Dalian, Northeast China: a cross-sectional study. BMC Public Health, 21 (1): 6. https://doi.org/10.1186/s12889-020-10055-2. Chen, X., Du, L. and Wu, R. 2012. Tuberculosis-related stigma and its determinants in Dalian, Northeast China: a cross-sectional study. BMC Public Health , 21, 6 https://doi.org/10.1186/s12889-020-10055-2. Thomas, B.E., Shanmugam, P., Malaisamy, M., Ovung, S., Suresh, C., Subbaraman, R., Adinarayanan, S. and Nagarajan, K. 2016. Psycho-Socioeconomic issues challenging multidrug-resistant tuberculosis patients: a systematic review. PLoS One, 11(1): e0147397. doi:10.1371/journal.pone.0147397. Dodor, E. A. 2012. The feelings and experiences of patients with tuberculosis in the Sekondi-Takoradi Metropolitan district: implications for TB control efforts. Ghana Med J, 46(4):211-218. Cremers, A. L., de Laat, M. M., Kapata, N., Gerrets, R., Klipstein-Grobusch, K. and Grobusch, M. P. 2015. Assessing the Consequences of Stigma for Tuberculosis Patients in Urban Zambia. PLoS ONE, 10(3):e0119861.doi:10.1371/journal.pone.0119861. Sommerland, N., Wouters, E., Mitchell, E.M.H., Ngicho, M., Redwood, L., Masquillier, C., van Hoorn, R., van den Hof, S. and Van Rie, A. 2017. Evidence-based interventions to reduce tuberculosis stigma: a systematic review. Int J Tuberc Lung Dis, 21(11): S81–S86. Dodor, E.A., Kelly, S. and Neal, K. 2009. Health professionals as stigmatisers of tuberculosis: Insights from community members and patients with TB in an urban district in Ghana. Psychol Health Med, 4(3): 301-310. World Health Organisation. Global Tuberculosis Report 2023. Retrieved January 14, 2025, https://www.who.int/publications/i/item/9789240101531. Abioye, I. A., Omotayo, M. O. and Alakija, W. 2011. Sociodemographic determinants of stigma among patients with pulmonary tuberculosis in Lagos, Nigeria. Afr Health Sci , 11(Suppl 1): S100–S104. Datiko, D.G., Jerene, D. and Suarez, P. 2020. Stigma matters in ending tuberculosis: Nationwide survey of stigma in Ethiopia. BMC Public Health , 20(1): 190. Available: doi: 10.1186/s12889-019-7915-6. Chen, X., Xu, J., Chen, Y., Wu, R., Ji, H., Pan, Y., Duan, Y., Sun, M., Du, L., Gao, M., Wang, J. and Zhou, L. 2021. The relationship among social support, experienced stigma, psychological distress, and quality of life among tuberculosis patients in China. Sci Rep, 11(1): https://doi.org/10.1038/s41598-021-03811-w Shringarpure, K.S., Isaakidis, P., Sagili, K.D., Baxi, R.K., Das, M., Daftary, A. 2016. When Treatment Is More Challenging than the Disease: A Qualitative Study of MDR-TB Patient Retention. PLoS ONE, 11 (3):e0150849. Available: doi:10.1371/journal.pone.0150849. Adejumo, O.A., Haffejee, F., Jinabhai, C. and Daniel, O. 2024. Association between experienced stigma, anxiety, depression and loneliness among people with drug-resistant tuberculosis in Lagos Nigeria: The moderating role of social support. Trop Med Int Health , 29(10): 882-894. doi: 10.1111/tmi.14046. Redwood, L., Fox, G.J., Nguyen, T.A., Bernarys, S., Mason, P., Vu, V.A., Nguyen, V.N., Mitchell, E.M.H. 2022. Good citizens, perfect patients, and family reputation: Stigma and prolonged isolation in people with drug-resistant tuberculosis in Vietnam. PLOS Glob Public Health, 2(6): e0000681. doi: 10.1371/journal.pgph.0000681. Cramm, J. M. and Nieboer, A. P. 2011. The relationship between (stigmatizing) views and lay public preferences regarding tuberculosis treatment in the Eastern Cape, South Africa. Int J Equity Health, 10 (2): 1-7. Daftary, A., Padayatchi, N. and O’Donnell. M. 2014. Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV coinfected patients in South Africa. Glob Public Health, 9:1107–1116. Nyblade, L., Stockton, M.A., Giger, K., Bond, V., Ekstrand, M.L., Lean, R.M., Mitchell, E.M.H., Nelson, R.E., Sapag, J.C., Siraprapasiri, T., Turan, J. and Wouters, E. 2019. Stigma in health facilities: Why it matters and how we can change it. BMC Medicine , 17(1): 25. Available: https://doi.org/10.1186/s12916-019-1256-2. Lyakurwa, D., Lyimo, J., Mulder, C., Pelzer, P.T., Koppelaar, I. and Heus M. 2021. Assessment of training and mentoring for DR-TB care decentralisation in Tanzania. Hum Resour Health, 9(1):56. doi:10.1186/s12960-021-00600-4 Probandari, A., Sanjoto, H., Mahanani, M.R., Azizatunnisa, L. and Widayati. S. 2019. Being safe, feeling safe, and stigmatising attitude among primary health care staff in providing multidrug-resistant tuberculosis care in Bantul District, Yogyakarta Province, Indonesia. Hum Resour Health, 17(1):16. doi:10.1186/s12960-019-0354-8. Vanleeuw, L., Atkins, S., Zembe-Mkabile, W. and Loveday, M. 2020. Provider perspectives of the introduction and implementation of care for drug-resistant tuberculosis patients in district level facilities in South Africa: a qualitative study. BMJ Open, 10(2):e032591. doi:10.1136/bmjopen-2019-032591. Daftary, A. and Padayatchi, N. 2016. Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study. Int J Tuberc Lung Dis, 20(11):1483-1488. Liboon, A.L., Alam, K., Gyawali, P. and Alam RM. 2023. Drug-Resistant Tuberculosis Stigma Among HealthCare Workers Toward the Development of a Stigma-Reduction Strategy: A Scoping Review. Inquiry, 60:469580231180754. doi: 10.1177/00469580231180754. Daftary, A., Mondal, S., Zelnick, J., Friedland, G., Seepamore, B., Boodhram, R., Amico, K.R., Padayatchi, N. and O'Donnell, M.R. 2021. Dynamic needs and challenges of people with drug-resistant tuberculosis and HIV in South Africa: a qualitative study. Lancet Glob Health, 9(4): doi: 10.1016/S2214-109X(20)30548-9. Sharma N. We cannot cure TB without curing TB stigma. Health Policy Watch 2024. Available at https://healthpolicy-watch.news/we-cannot-cure-tb-without-curing-tb-stigma/ (Accessed 30, March 2025). Table Additional Declarations No competing interests reported. Supplementary Files FocusGroupDiscussionGuide.docx Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-6397399","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":453428555,"identity":"ac6c9063-3798-4238-bf2d-71ebc4e973cc","order_by":0,"name":"Olusola A. Adejumo","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAABC0lEQVRIie3QvUrDUBTA8RMvpMuBrCfUhzihEAsW8yq3BJwyKC4FoV7pkMUHyGPoG9wSsEsfIKBgXDoJpotTKJ7OegluDve//zgfAD7fPywardbt/HDACDQAXVE0SOKH55y70J7GRgdmyhSbIcJNkcZVaGdshSwYhglYnY4RX3GyKc7ahqeymXrvoL9wisDY/Bxph+n2I7mvmGSzcEKAuZOowKxfkBWmTZGsiGnJFlJ5hHKSUMwYtcJJJaSXKZkdfcmNd06CoTqJK1sjU5EYmUIMKFN07SQkhvfmEmm7u66OhGq8IW03TpK9fe7buZllUZk/drRYUlSWT13X3zrJLx0P138BPp/P5/vRN9MdTtWvgS3lAAAAAElFTkSuQmCC","orcid":"","institution":"Durban University of Technology","correspondingAuthor":true,"prefix":"","firstName":"Olusola","middleName":"A.","lastName":"Adejumo","suffix":""},{"id":453428556,"identity":"f2866bd2-b03c-405a-8808-2d8b8e5c74e1","order_by":1,"name":"Firoza Haffejee","email":"","orcid":"","institution":"Durban University of Technology","correspondingAuthor":false,"prefix":"","firstName":"Firoza","middleName":"","lastName":"Haffejee","suffix":""},{"id":453428557,"identity":"dc260a99-284b-42a2-9e7a-53d6ecd35685","order_by":2,"name":"Olusoji Daniel","email":"","orcid":"","institution":"Olabisi Onabanjo University","correspondingAuthor":false,"prefix":"","firstName":"Olusoji","middleName":"","lastName":"Daniel","suffix":""},{"id":453428558,"identity":"567e4dc1-2c4c-43b5-80ce-54c74785fecf","order_by":3,"name":"Champaklal Jinabhai","email":"","orcid":"","institution":"Durban University of Technology","correspondingAuthor":false,"prefix":"","firstName":"Champaklal","middleName":"","lastName":"Jinabhai","suffix":""}],"badges":[],"createdAt":"2025-04-07 21:23:08","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-6397399/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-6397399/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":106399311,"identity":"b3214a59-4ab8-4463-a5f7-52576b3bdc0b","added_by":"auto","created_at":"2026-04-08 08:29:10","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":559237,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-6397399/v1/ef138e4d-b798-4d92-be8a-a572e3589158.pdf"},{"id":82247562,"identity":"50cccf2f-c283-49cb-b74b-29b47b81d2d8","added_by":"auto","created_at":"2025-05-08 09:25:24","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":38925,"visible":true,"origin":"","legend":"","description":"","filename":"FocusGroupDiscussionGuide.docx","url":"https://assets-eu.researchsquare.com/files/rs-6397399/v1/7f45e023c28f40fd52134e7a.docx"}],"financialInterests":"No competing interests reported.","formattedTitle":"\u003cp\u003e‘The way they treat us is worse than the disease’: A qualitative study of the experiences of people with drug-resistant tuberculosis at healthcare facilities in Lagos, Nigeria\u003c/p\u003e","fulltext":[{"header":"Introduction","content":"\u003cp\u003eTuberculosis (TB) is a stigmatised disease affecting mainly socially disadvantaged people, such as poor people, prisoners and refugees, and people living with HIV/AIDS [\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e]. In most high TB-burden societies, TB-related stigma is a major sociocultural factor affecting the disease experience of people living with TB (PLWTB) because it influences the attitudes and behaviors of the community towards them [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e]. It is shaped by deep-rooted myths and customs, incorrect perceptions and belief systems, and the culture of healthcare institutions [\u003cspan additionalcitationids=\"CR4\" citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eTB-related stigma can affect the health-seeking and healthcare-seeking behavior of symptomatic individuals. It hinders the disclosure of disease to family members and friends, encourages community spread, and undermines TB control efforts [\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e]. Because of the fear of contagion, many PLWTB are not treated well by family members, friends, neighbours, or healthcare workers (HCWs), which may lead to low self-esteem, feelings of shame and guilt, isolation, and psychological distress [\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e]. TB-related stigma is common among people with drug-resistant TB (PwDR-TB) because of the longer duration of treatment, the perceived severity of the disease, and the shame associated with poor treatment outcomes [\u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eStigma is a social construct comprising two significant components: identifying a differentiating trait or attribute and labelling or discrediting the individual due to that trait [\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e]. The attitudes of the community, especially HCWs, towards PLWTB may impact the timing, place, duration, and effectiveness of the care they receive [\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e, \u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e]. HCWs occupy a position that can define a disease with negative attributes and influence the community's perception of it, consequently reinforcing the stigma attached to the disease by the community [\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eTB is still a disease of public health concern in Nigeria despite all TB control efforts. Nigeria is one of the 30 high-burden countries for TB, accounting for 87% of the global incidence of TB cases. Among the 408,500 people diagnosed with drug-resistant TB (DR-TB) in 2022 globally, 57% were not enrolled, and Nigeria is among the 10 countries that accounted for 70% of the gap in treatment initiation [\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e]. Studies from high-burden TB countries such as Nigeria, Ethiopia, and China have reported a high prevalence of TB-related stigma [\u003cspan additionalcitationids=\"CR14\" citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e]. The poor treatment of PLWTB in healthcare settings has been documented. Reports from Ghana and India have shown that HCWs are unfriendly towards, shunned, shouted at, avoided, disrespected, and discriminated against PLWTB [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e, \u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e]. Another qualitative study from Ghana revealed that the isolation and precautionary practices and behaviours of HCWs towards PLWTB exposed them to stigmatisation in the community [\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e]. TB cannot be controlled without strategies in place to reduce stigma, and TB control in Nigeria is crucial to global control due to its high prevalence in the country. Based on the above narrative, TB patients' experiences in Nigeria's healthcare facilities require further exploration. Unfortunately, there is a dearth of such studies in Nigeria. This study examines the stigma experiences of PwDR-TB in healthcare facilities in Lagos, Nigeria.\u003c/p\u003e"},{"header":"Methods","content":"\u003cp\u003eThis study was part of a larger study that assessed the moderating role of social support in the associations among experienced stigma, anxiety, depression and loneliness among PwDR-TB in Lagos, Nigeria [\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e]. The study was conducted in Lagos state, Nigeria, between September and December 2023. Lagos State is a commercial hub in Nigeria, with an estimated population of 21\u0026nbsp;million. The state is divided into 20 local government areas (LGAs) and 37 local council development areas (LCDAs). The participants were drawn from five DR-TB outpatient clinics in Lagos State.\u003c/p\u003e \u003cp\u003e The study received ethical approval from the Institutional Research Ethics Committee of the Durban University of Technology, South Africa (IREC 066/230) and the Health Research and Ethics Committee of the Lagos State University Teaching Hospital (LREC/06/10/2179). The Lagos State Ministry of Health granted permission for the interviews with participants. The data were collected in five DR-TB treatment centers across Lagos State between February and April 2024. The five centers were purposively selected because of their geographical representation and diversity of patients, as well as their high volume of clinic attendance. Furthermore, patients reported unpleasant discriminatory experiences in some of these health facilities. Details about the study site selection were published previously [\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eFive focus group discussions (FGDs) were conducted, one at each of the selected health facilities, and 53 participants (27 males and 26 females) aged 18\u0026ndash;53 years participated in the discussions. Discussions were held at the outpatient clinic. Participants who took part in the larger study were invited to participate in the FGDs. Eligible participants were people who commenced DR-TB treatment within three months of the interview or who had completed treatment and were not younger than 18 years [\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e]. Details of the focus group participants are shown in Table\u0026nbsp;1.\u003c/p\u003e \u003cp\u003eThe focus groups were held at the health facility after the outpatient clinic and were moderated by the first author. Three research assistants were trained to assist with data collection, including recording discussions on audio tapes, note-taking, and transcribing the audio tapes. Each interview consisted of 9\u0026ndash;12 participants and lasted 60\u0026ndash;75 minutes. Focus group sessions were conducted in English and pidgin English using a focus group guide developed for this study (See supplementary file 1). Two bilingual research assistants translated and transcribed the recorded audio tapes verbatim within 48 hours after the data collection activity. After this, the first author and another research assistant, who had not participated in the initial transcription, used the audio tapes and field notes to verify the transcriptions and ensure that the participants' words were accurately preserved and that correct transcriptions were produced. The whole team was involved in resolving conflicts in interpretation and achieving a consensus. All coauthors read the transcripts several times and scrutinised them. A codebook was developed, and the transcripts were tabulated into three themes to facilitate comparison by two coauthors. These themes encompass the attitudes of healthcare workers, the effects of these attitudes, and the isolation that results from the education of healthcare workers. The coders discussed the data to ensure consistency in the meaning of the codes and assure interrater reliability. Verbatim quotations were selected to represent repeated discussions and ideas.\u003c/p\u003e"},{"header":"Results","content":"\u003cdiv id=\"Sec4\" class=\"Section2\"\u003e\n \u003ch2\u003e1. Attitudes of health workers\u003c/h2\u003e\n \u003cp\u003eMany participants complained about the attitudes of the HCWs. They described their attitudes as demeaning because the HCWs were very rude, shouted at some, and made some uncomplimentary remarks about others.\u003c/p\u003e\n \u003cp\u003e\u003cem\u003e\u0026hellip; on my first visit here, I felt like the whole world was against me; the nurse made me think I was different, that there was something wrong with me, and she did not want me to come close to her. I don\u0026rsquo;t want to come here if I can buy the medication elsewhere, I won\u0026rsquo;t come here\u0026hellip; (female, participant, 38 years old, FGD 2)\u003c/em\u003e\u003c/p\u003e\n \u003cp\u003e\u003cem\u003e\u0026hellip;.. when I arrived at the hospital, I gave the doctor the test results. Immediately, she saw what was there; she said, \u0026apos;Madam, go outside.\u0026apos; She then went and put on two face masks. She asked anybody who sat beside me to move away from me. When more people arrived, she chased me away from the clinic and asked me to sit outside. I fell while trying to exit the clinic. The disgrace was too much (female participant, 43 years old, FGD 5)\u003c/em\u003e\u003c/p\u003e\n \u003cp\u003eSome of the participants wanted to abandon treatment because of the way they were attended to. Some even wish to die because of the attitudes of HCWs.\u003c/p\u003e\n \u003cp\u003e\u003cem\u003e\u0026hellip;\u0026hellip;. We sat down to see the doctor. When the nurse collected our test results, she shouted, \u0026quot;Go and sit down first.\u0026rdquo; She shouted at us to stand up and chased us away like animals. As we tried to move out of the place quickly, my child hit his head on an iron. I was so embarrassed, I thought of abandoning the treatment and dying \u0026hellip;. (female participant, 45 years old, FGD 4).\u003c/em\u003e\u003c/p\u003e\n \u003cp\u003eSome participants wished that they could report the HCWs to a higher authority for their bad attitudes, but some could not take this step because they did not want people to know that they had DR-TB.\u003c/p\u003e\n \u003cp\u003e\u003cem\u003e\u0026hellip; the moment the woman saw my result, her attitude towards me changed; she shouted and embarrassed me. People asked me what went wrong. If I had the power, I would have reported her because I was treated as if I had leprosy\u0026hellip;.(male participant, 43 years old, FGD 1)\u003c/em\u003e\u003c/p\u003e\n \u003cp\u003e\u003cem\u003e\u0026hellip;I had to endure the way the health workers treated me; I felt terrible, but I kept it to myself. I am the sick one, and I don\u0026rsquo;t want anybody to know I have TB\u0026hellip;. (male participant, 48 years old, FGD 3)\u003c/em\u003e\u003c/p\u003e\n\u003c/div\u003e\n\u003ch3\u003e2. Effects of healthcare workers\u0026rsquo; attitudes\u003c/h3\u003e\n\u003cp\u003eSome participants reported experiencing adverse effects due to the poor attitudes of healthcare workers. Some felt humiliated, and some described the experience as being worse than the symptoms and the side effects of the drugs.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026hellip;..the way I am being treated matters more to me than the TB itself; my first experience at the health facility was terrible (female participant, 25 years old, FGD 3).\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026hellip;\u0026hellip;\u0026hellip; I told him it\u0026rsquo;s not about the free medication; it\u0026rsquo;s about the humiliation (female participant, 35 years old, FGD 2)\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eOwing to the attitudes of HCWs, some participants reported that it took courage to visit healthcare facilities to receive treatment. They could have opted for other options if possible.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026hellip;... It takes courage to come here; the way I am being treated could increase the problems I already have. If there were other options, I would not come here again\u0026hellip; (male participant, 41 years old, FGD 5)\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eAll the participants agreed that discriminatory behaviours were worse at the health facility than in the community. They reported that because they do not usually disclose their sickness to neighbours and friends, they do not become stigmatised. When asked if there is any other place they are discriminated against more than the health facility, they all chorused, \u0026ldquo;nowhere is worse than the health facility.\u0026rdquo;\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026hellip;Nowhere was I treated poorly except at the health facility. In the neighbourhood, nobody can know you have the disease\u0026hellip; (male participant, 43 years old, FGD 2)\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026hellip; this (referring to the hospital) is where we wear a face mask; at home, we are just like any other person; no one knows what\u0026rsquo;s wrong with us. (male participant, 25 years old, FGD 1)\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003e3. Healthcare workers were responsible for isolation practices at home.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eMany participants recounted the health education provided by HCWs. This includes unfounded practices, which involve using separate cutlery, sleeping in separate rooms, and avoiding the items used by PLWTB. This advice caused severe emotional trauma to the PLWTB.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026hellip;.. they (the healthcare workers) usually ask me if I am using my medications and who I live with. They advised that I should not share utensils with anyone, use my face mask properly, and they told me to ensure that I don\u0026rsquo;t miss my drugs and always come for check-ups. (male participant, 20 years old, FGD 3).\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026hellip;I became lonely. Even my wife now stays away from me. We were sleeping in the same room, but now she is far from me. They advised us not to share anything (male participant, 45 years old, FGD 1)\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eHowever, some family members showed a greater understanding of their loved ones. They were cognizant of the psychological effects of not sharing items within the household.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026hellip;at the hospital, they told us that my husband should not share my spoon or share a cup or anything with me. However, my husband refused; he said he did not want what they said would affect me (female participant, 42 years old, FGD 2).\u003c/em\u003e\u003c/p\u003e"},{"header":"Discussion","content":"\u003cp\u003eThis study provides insight into the experiences of PwDR-TB at healthcare facilities. Health professionals hold a privileged position to shape society\u0026rsquo;s perspective on any disease, owing to their specialised knowledge and social authority. Therefore, any human differences labelled by health professionals are accepted by society [\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e]. In some African countries, the practices and attitudes of HCWs are associated with stigmatisation. HCWs blame and impose restrictive practices that promote stigma. For example, in Ghana, HCWs impose that relatives are not allowed to see the PLWTB, shout at patients, run away when patients approach them and prohibit burial rites for people who die of TB [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e, \u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e]. In South Africa, poor attitudes toward providing grants, information, or treatment for TB have contributed to stigmatisation [\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e]. In Ethiopia, private providers are preferred over public TB healthcare providers because of the associated stigma [\u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eThis study highlights the struggles and challenges faced by PwDR-TB at healthcare facilities in Lagos, Nigeria. They were exposed to a system that labelled them as different and dangerous. They had to cope with the demeaning attitudes and behaviours of HCWs. These experiences were previously documented [\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e, \u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e]. All the participants echoed that their greatest stigma challenge was at the healthcare facility. Many of the participants lamented the treatment they received from some HCWs. One participant described the treatment at the healthcare facility as worse than the symptoms of DR-TB. They craved acceptance, understanding, and empathy from the HCWs. We previously reported that social support reduced the effects of stigma on anxiety, loneliness, and depression among PwDR-TB in Lagos [\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e]. Getting the needed support from HCWs will significantly reduce the burden of DR-TB treatment. Studies have shown that HCWs working in DR-TB wards are hostile to patients because of the fear of infection [\u003cspan additionalcitationids=\"CR23\" citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e], poor workplace infection prevention and control practices [\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e, \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e], lack of knowledge of infection control (IC) guidelines [\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e, \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e] and lack confidence in the facility\u0026rsquo;s ability to provide DR-TB care [\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eThere is a paucity of TB stigma reduction intervention programs. A study indicated that training HCWs in IC and enhancing administrative and operational IC standards could help reduce barriers to implementing IC but not the fear of infection [\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e]. The provision of infrastructure for sustainability must support the training of HCWs. This will reduce the stigma faced by HCWs working with PLWTB experience from colleagues not working with PLWTB.\u003c/p\u003e \u003cp\u003eThere is a need for continual mentoring and supportive supervision. This is essential to HCWs\u0026rsquo; confidence in providing DR-TB care [\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e]. Faith-based interventions that have improved the quality of life among people living with HIV/AIDS and financial aid could strengthen PwDR-TB resilience to stigma [\u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eIn conclusion, this study helps elucidate the stigma experienced by PwDR-TB in healthcare facilities. This study also shows that TB-related stigma could be significantly reduced if healthcare-associated stigma is minimised. To address stigma, there is a need for patient education and a support structure to build resilience and empower patients as they navigate the disease. Nigeria can learn from Ethiopia and Nicaragua, where small groups of patients often meet to support one another throughout the treatment period [\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e]. This will help reduce the social isolation that patients typically experience. There is a need for community engagement, which provides an enabling environment for PLWTB to share their experiences and advocate for changes in social norms that reinforce stigma. Additionally, there is a need to train HCWs to engage PLWTB and their families, provide the necessary infrastructure to optimise IC in healthcare facilities and offer supportive supervision and mentoring to HCWs. There is a need for stigma reduction intervention research in Nigeria and learning from other settings that have achieved relative success.\u003c/p\u003e"},{"header":"Abbreviations","content":"\u003cp\u003eDR-TB\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Drug-resistant tuberculosis\u003c/p\u003e\n\u003cp\u003eFGDs\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;Focus Group Discussions\u003c/p\u003e\n\u003cp\u003eHCWs\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;Healthcare workers\u003c/p\u003e\n\u003cp\u003eHIV/AIDS\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;Human immune deficiency syndrome/ Acquired Immune deficiency syndrome\u003c/p\u003e\n\u003cp\u003eIC\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Infection control\u003c/p\u003e\n\u003cp\u003eLCDAs\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Local Council Development Areas\u003c/p\u003e\n\u003cp\u003eLGAs\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;Local Government Areas\u003c/p\u003e\n\u003cp\u003ePLWTB\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;People living with tuberculosis\u003c/p\u003e\n\u003cp\u003eTB\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;Tuberculosis\u003c/p\u003e\n\u003cp\u003ePwDR-TB \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; People with drug-resistant tuberculosis\u003c/p\u003e"},{"header":"Statements and declarations","content":"\u003cp\u003e\u003cstrong\u003eEthical approval:\u0026nbsp;\u003c/strong\u003e\u003cem\u003eThis study was performed in\u0026nbsp;\u003c/em\u003e\u003cem\u003eaccordance\u003c/em\u003e\u003cem\u003e\u0026nbsp;with the principles of the Declaration of Helsinki. Approval was granted by the\u0026nbsp;\u003c/em\u003eHealth Research and Ethics Committee of the Lagos State University Teaching Hospital (LREC/06/10/2179) and the Institutional Research Ethics Committee of Durban University of Technology, South Africa (IREC 066/230). Gatekeepers’ permission to interview participants was obtained from the Lagos State Ministry of Health and the medical directors of the DR-TB treatment centres where participants were recruited.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eInformed consent:\u0026nbsp;\u003c/strong\u003eWritten informed consent\u0026nbsp;\u003cem\u003ewas obtained from all participants included in the study. The study's objectives were explained to the participants. They were also informed that participation or\u0026nbsp;\u003c/em\u003e\u003cem\u003enonparticipation\u003c/em\u003e\u003cem\u003e\u0026nbsp;in the study would not affect the provision of healthcare services. In addition, they were told that they were free to withdraw their consent at any time during the study. The data\u0026nbsp;\u003c/em\u003e\u003cem\u003ewere\u003c/em\u003e\u003cem\u003e\u0026nbsp;anonymised, and personal identifiers were not obtained.\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eConsent for publication:\u003c/strong\u003e\u003c/em\u003e\u003cem\u003e\u0026nbsp;Not applicable.\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eAvailability of data and materials:\u003c/strong\u003e\u003c/em\u003e\u003cem\u003e\u0026nbsp;T\u003c/em\u003ehe datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompeting interest:\u003c/strong\u003e\u003cem\u003eThe authors have no relevant financial or\u0026nbsp;\u003c/em\u003e\u003cem\u003enonfinancial\u003c/em\u003e\u003cem\u003e\u0026nbsp;interests to disclose.\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eFunding:\u003c/strong\u003e\u003c/em\u003e\u003cem\u003e\u0026nbsp;The authors declare that no funds, grants, or other support\u0026nbsp;\u003c/em\u003e\u003cem\u003ewere\u003c/em\u003e\u003cem\u003e\u0026nbsp;received during the preparation of this manuscript.\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors' contributions:\u0026nbsp;\u003c/strong\u003eOAA conceived the study, analysed the data, and prepared the manuscript. OAA and FH were involved in the study design, literature search and coding of the\u0026nbsp;transcripts.\u0026nbsp;CJ,\u0026nbsp;OD\u0026nbsp;and\u0026nbsp;FH\u0026nbsp;were\u0026nbsp;involved\u0026nbsp;in\u0026nbsp;interpreting\u0026nbsp;the\u0026nbsp;data and coding.\u0026nbsp;FH, CJ and OD critically revised the manuscript for intellectual content. All the\u0026nbsp;authors read and approved the final manuscript. OAA, FH and OD are guarantors of the manuscript.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcknowledgements:\u003c/strong\u003e The authors wish to acknowledge the Lagos State Ministry of Health and the Lagos State TB and Leprosy Control Programme for granting permission to conduct this study. We also acknowledge the assistance and support of the management of the DR-TB treatment centres where the study was conducted. Special thanks to Nnenna Karen Ihezie for working tirelessly during the coding of the transcripts.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n \u003cli\u003eAshaba, C., Musoke, D., Wafula, S. T. and Konde-Lule J. 2021 Stigma among tuberculosis patients and associated factors in urban slum populations in Uganda. \u003cem\u003eAfri Health Sci,\u003c/em\u003e 21(4),1640-1650.\u003c/li\u003e\n \u003cli\u003eDodor, E. A. and Kelly, S. J. 2010. Manifestations of tuberculosis stigma within the healthcare system: the case of Sekondi-Takoradi Metropolitan district in Ghana. \u003cem\u003eHealth Policy,\u003c/em\u003e 98,195-202.\u003c/li\u003e\n \u003cli\u003eCourtwright, A. and Turner, A. N. 2010. Tuberculosis and stigmatization: pathways and interventions. \u003cem\u003ePublic Health Rep\u003c/em\u003e, 125, 34-42.\u003c/li\u003e\n \u003cli\u003eNuttall, C., Fuady, A., Nuttall, H., Dixit, K., Mansyur, M. and Wingfield, T. 2022. Interventions pathways to reduce tuberculosis-related stigma: a literature review and conceptual framework. \u003cem\u003eInfect Dis Poverty,\u003c/em\u003e 11(101). https://doi.org/10.1186/s40249-022-01021-8\u003c/li\u003e\n \u003cli\u003eChen, X., Du, L., Wu, R., Xu, J., Ji, H., Zhang, Y., Zhu, X. and Zhou, L. 2021. Tuberculosis-related stigma and its determinants in Dalian, Northeast China: a cross-sectional study. \u003cem\u003eBMC Public Health,\u003c/em\u003e 21 (1): 6. https://doi.org/10.1186/s12889-020-10055-2.\u003c/li\u003e\n \u003cli\u003eChen, X., Du, L. and Wu, R. 2012. Tuberculosis-related stigma and its determinants in Dalian, Northeast China: a cross-sectional study. \u003cem\u003eBMC Public Health\u003c/em\u003e, 21, 6 https://doi.org/10.1186/s12889-020-10055-2.\u003c/li\u003e\n \u003cli\u003eThomas, B.E., Shanmugam, P., Malaisamy, M., Ovung, S., Suresh, C., Subbaraman, R., Adinarayanan, S. and Nagarajan, K. 2016. Psycho-Socioeconomic issues challenging multidrug-resistant tuberculosis patients: a systematic review. \u003cem\u003ePLoS One,\u003c/em\u003e 11(1): e0147397. doi:10.1371/journal.pone.0147397.\u003c/li\u003e\n \u003cli\u003eDodor, E. A. 2012. The feelings and experiences of patients with tuberculosis in the Sekondi-Takoradi Metropolitan district: implications for TB control efforts. \u003cem\u003eGhana Med J,\u003c/em\u003e 46(4):211-218.\u003c/li\u003e\n \u003cli\u003eCremers, A. L., de Laat, M. M., Kapata, N., Gerrets, R., Klipstein-Grobusch, K. and Grobusch, M. P. 2015. Assessing the Consequences of Stigma for Tuberculosis Patients in Urban Zambia. \u003cem\u003ePLoS ONE,\u003c/em\u003e 10(3):e0119861.doi:10.1371/journal.pone.0119861.\u003c/li\u003e\n \u003cli\u003eSommerland, N., Wouters, E., Mitchell, E.M.H., Ngicho, M., Redwood, L., Masquillier, C., van Hoorn, R., van den Hof, S. and Van Rie, A. 2017. Evidence-based interventions to reduce tuberculosis stigma: a systematic review. \u003cem\u003eInt J Tuberc Lung Dis,\u003c/em\u003e 21(11): S81\u0026ndash;S86.\u003c/li\u003e\n \u003cli\u003eDodor, E.A., Kelly, S. and Neal, K. 2009. Health professionals as stigmatisers of tuberculosis: Insights from community members and patients with TB in an urban district in Ghana. \u003cem\u003ePsychol Health Med,\u003c/em\u003e 4(3): 301-310.\u003c/li\u003e\n \u003cli\u003eWorld Health Organisation. Global Tuberculosis Report 2023. Retrieved January 14, 2025, https://www.who.int/publications/i/item/9789240101531.\u003c/li\u003e\n \u003cli\u003eAbioye, I. A., Omotayo, M. O. and Alakija, W. 2011. Sociodemographic determinants of stigma among patients with pulmonary tuberculosis in Lagos, Nigeria. \u003cem\u003eAfr Health Sci\u003c/em\u003e, 11(Suppl 1): S100\u0026ndash;S104.\u003c/li\u003e\n \u003cli\u003eDatiko, D.G., Jerene, D. and Suarez, P. 2020. Stigma matters in ending tuberculosis: Nationwide survey of stigma in Ethiopia. \u003cem\u003eBMC Public Health\u003c/em\u003e, 20(1): 190. Available: doi: 10.1186/s12889-019-7915-6.\u003c/li\u003e\n \u003cli\u003eChen, X., Xu, J., Chen, Y., Wu, R., Ji, H., Pan, Y., Duan, Y., Sun, M., Du, L., Gao, M., Wang, J. and Zhou, L. 2021. The relationship among social support, experienced stigma, psychological distress, and quality of life among tuberculosis patients in China. \u003cem\u003eSci Rep,\u0026nbsp;\u003c/em\u003e11(1): https://doi.org/10.1038/s41598-021-03811-w\u003c/li\u003e\n \u003cli\u003eShringarpure, K.S., Isaakidis, P., Sagili, K.D., Baxi, R.K., Das, M., Daftary, A. 2016. When Treatment Is More Challenging than the Disease: A Qualitative Study of MDR-TB Patient Retention. \u003cem\u003ePLoS ONE,\u0026nbsp;\u003c/em\u003e11 (3):e0150849. Available: doi:10.1371/journal.pone.0150849.\u003c/li\u003e\n \u003cli\u003eAdejumo, O.A., Haffejee, F., Jinabhai, C. and Daniel, O. 2024. Association between experienced stigma, anxiety, depression and loneliness among people with drug-resistant tuberculosis in Lagos Nigeria: The moderating role of social support. \u003cem\u003eTrop Med Int Health\u003c/em\u003e, 29(10): 882-894. doi: 10.1111/tmi.14046.\u003c/li\u003e\n \u003cli\u003eRedwood, L., Fox, G.J., Nguyen, T.A., Bernarys, S., Mason, P., Vu, V.A., Nguyen, V.N., Mitchell, E.M.H. 2022. Good citizens, perfect patients, and family reputation: Stigma and prolonged isolation in people with drug-resistant tuberculosis in Vietnam. \u003cem\u003ePLOS Glob Public Health,\u003c/em\u003e 2(6): e0000681. doi: 10.1371/journal.pgph.0000681.\u003c/li\u003e\n \u003cli\u003eCramm, J. M. and Nieboer, A. P. 2011. The relationship between (stigmatizing) views and lay public preferences regarding tuberculosis treatment in the Eastern Cape, South Africa. \u003cem\u003eInt J Equity Health,\u003c/em\u003e 10 (2): 1-7.\u003c/li\u003e\n \u003cli\u003eDaftary, A., Padayatchi, N. and O\u0026rsquo;Donnell. M. 2014. Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV coinfected patients in South Africa. \u003cem\u003eGlob Public Health,\u003c/em\u003e 9:1107\u0026ndash;1116.\u003c/li\u003e\n \u003cli\u003eNyblade, L., Stockton, M.A., Giger, K., Bond, V., Ekstrand, M.L., Lean, R.M., Mitchell, E.M.H., Nelson, R.E., Sapag, J.C., Siraprapasiri, T., Turan, J. and Wouters, E. 2019. Stigma in health facilities: Why it matters and how we can change it. \u003cem\u003eBMC Medicine\u003c/em\u003e, 17(1): 25. Available: https://doi.org/10.1186/s12916-019-1256-2.\u003c/li\u003e\n \u003cli\u003eLyakurwa, D., Lyimo, J., Mulder, C., Pelzer, P.T., Koppelaar, I. and Heus M. 2021. Assessment of training and mentoring for DR-TB care decentralisation in Tanzania. \u003cem\u003eHum Resour Health,\u003c/em\u003e 9(1):56. doi:10.1186/s12960-021-00600-4\u003c/li\u003e\n \u003cli\u003eProbandari, A., Sanjoto, H., Mahanani, M.R., Azizatunnisa, L. and Widayati. S. 2019. Being safe, feeling safe, and stigmatising attitude among primary health care staff in providing multidrug-resistant tuberculosis care in Bantul District, Yogyakarta Province, Indonesia. \u003cem\u003eHum Resour Health,\u003c/em\u003e17(1):16. doi:10.1186/s12960-019-0354-8.\u003c/li\u003e\n \u003cli\u003eVanleeuw, L., Atkins, S., Zembe-Mkabile, W. and Loveday, M. 2020. Provider perspectives of the introduction and implementation of care for drug-resistant tuberculosis patients in district level facilities in South Africa: a qualitative study. \u003cem\u003eBMJ Open,\u003c/em\u003e 10(2):e032591. doi:10.1136/bmjopen-2019-032591.\u003c/li\u003e\n \u003cli\u003eDaftary, A. and Padayatchi, N. 2016. Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study. \u003cem\u003eInt J Tuberc Lung Dis,\u0026nbsp;\u003c/em\u003e20(11):1483-1488.\u003c/li\u003e\n \u003cli\u003eLiboon, A.L., Alam, K., Gyawali, P. and Alam RM. 2023. Drug-Resistant Tuberculosis Stigma Among HealthCare Workers Toward the Development of a Stigma-Reduction Strategy: A Scoping Review. \u003cem\u003eInquiry,\u003c/em\u003e 60:469580231180754. doi: 10.1177/00469580231180754.\u003c/li\u003e\n \u003cli\u003eDaftary, A., Mondal, S., Zelnick, J., Friedland, G., Seepamore, B., Boodhram, R., Amico, K.R., Padayatchi, N. and O\u0026apos;Donnell, M.R. 2021. Dynamic needs and challenges of people with drug-resistant tuberculosis and HIV in South Africa: a qualitative study. \u003cem\u003eLancet Glob Health,\u003c/em\u003e 9(4): doi: 10.1016/S2214-109X(20)30548-9.\u003c/li\u003e\n \u003cli\u003eSharma N. We cannot cure TB without curing TB stigma. Health Policy Watch 2024. Available at https://healthpolicy-watch.news/we-cannot-cure-tb-without-curing-tb-stigma/ (Accessed 30, March 2025).\u003c/li\u003e\n\u003c/ol\u003e"},{"header":"Table","content":"\u003cp\u003e\u003cimg src=\"data:image/png;base64,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\"\u003e\u003c/p\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Stigma, healthcare workers, drug-resistant tuberculosis, Nigeria","lastPublishedDoi":"10.21203/rs.3.rs-6397399/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-6397399/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eBackground: \u003c/strong\u003eThis study explored the stigma experiences of people with drug-resistant tuberculosis at health facilities in Lagos, Nigeria.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethods: \u003c/strong\u003eFocus group discussions were conducted with individuals receiving treatment for drug-resistant tuberculosis at five treatment centers in Lagos. Thematic analysis was conducted.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResults: \u003c/strong\u003eThe participants complained about the poor attitudes of healthcare workers, which they described as rude, hostile, and demeaning. These poor attitudes led some participants to consider abandoning treatment, whereasothers wished that they knew where to lodge complaints against healthcare workers. The participantsfelt humiliated, and some described the feeling as worse than the disease symptoms. The counselling by healthcare workers about the use of separate cutlery and self-isolation at home evoked feelings of loneliness at home, which was disapproved of by many participants.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion: \u003c/strong\u003eReducing healthcare-associated stigma will require training healthcare workers on how to engage with people living with tuberculosis and their families, as well as providingnecessary infrastructural support that will make healthcare workers feel safe working among people living with tuberculosis. There is a need for stigma reduction intervention research in Nigeria, as well as learning from other settings that have achieved relative success.\u003c/p\u003e","manuscriptTitle":"‘The way they treat us is worse than the disease’: A qualitative study of the experiences of people with drug-resistant tuberculosis at healthcare facilities in Lagos, Nigeria","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-05-08 09:25:19","doi":"10.21203/rs.3.rs-6397399/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"d030d403-8f31-408f-9e40-a1566e0dea83","owner":[],"postedDate":"May 8th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2026-04-08T08:26:35+00:00","versionOfRecord":[],"versionCreatedAt":"2025-05-08 09:25:19","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-6397399","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-6397399","identity":"rs-6397399","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}